Pfizer acquires AstraZeneca’s small molecule anti-infective business

25-08-2016

Pfizer acquires AstraZeneca’s small molecule anti-infective business

pio3 / Shutterstock.com

Pharmaceutical company Pfizer has acquired AstraZenecas small molecule anti-infective business, it was announced yesterday.


Pfizer, AstraZeneca, small molecule, mergers and acquisitions,

LSIPR